When a patient has a breast biopsy, most of the experience is understandably focused on what happens in the room. There is the preparation, the procedure itself, and then the waiting. Once the tissue sample leaves the room, however, a different part of the diagnostic process begins.
That is the part of medicine where I have spent much of my career.
As a breast pathologist, I have examined breast tissue and worked with other physicians involved in breast care. One thing I have learned is that patients often know relatively little about what happens to their biopsy after it is collected. That makes sense. Pathologists usually work behind the scenes, and many patients will never meet the physician examining their tissue.
I think it is worth understanding what happens during that period, particularly because pathology is not simply a matter of putting a specimen under a microscope and immediately knowing the answer.
The Biopsy Has to Become Something We Can Examine
After breast tissue is collected, it needs to be properly handled and prepared so that a pathologist can evaluate it under a microscope. There are several technical steps involved in preparing the original tissue into slides for study.
By the time I am looking at a slide, I am seeing a very thin section of tissue prepared specifically for microscopic examination. I am looking at how the cells and structures appear and how they relate to one another.
People sometimes imagine pathology as a visual matching exercise: look at the slide, recognize a pattern, and write down the diagnosis. There certainly is pattern recognition involved, but experience has taught me that the real work can be more nuanced.
What am I actually seeing? Does everything fit together? Is there something unusual here? Do I need additional information before I am comfortable reaching a conclusion?
Those questions are part of the work.
Not Every Breast Biopsy Is a Simple Yes-or-No Question
One misconception I would like patients to understand is that a breast biopsy is not always about answering only one question: cancer or no cancer.
Breast pathology covers a range of findings, and individual cases can have different levels of complexity. A pathologist has to evaluate what is actually present in the tissue rather than begin with the assumption that the answer will fit neatly into one of two categories.
That distinction becomes particularly important in unusual cases.
During my career, I have participated in scholarly work involving uncommon findings and diagnostic challenges in breast pathology. One case involved a rare acantholytic variant of metaplastic squamous cell carcinoma of the breast. Another involved metastatic breast carcinoma found in an endometrial polyp. These were unusual enough to become subjects of professional presentations.
Most routine biopsies are not rare case reports, of course. I mention these examples because they illustrate something I learned during my training and have continued to appreciate in practice: a pathologist cannot assume that every specimen will behave like the last one.
Sometimes the first impression is straightforward. Sometimes it raises another question.
Knowing the difference matters.
Why Might a Pathologist Need More Information?
Patients understandably want answers quickly. If I were waiting for an important medical result, I would want the same thing.
At the same time, pathology involves a balance between efficiency and being sufficiently thorough. There can be situations where additional evaluation is appropriate before a case is finalized. The exact circumstances depend on what is present in the specimen.
This is one reason I am cautious about describing pathology as a single moment of discovery. It is better understood as a process of evaluation.
A pathologist has to ask whether the findings make sense together and whether the available material supports the conclusion. In challenging cases, the responsible question is not simply, “What do I think this is?” It is also, “Do I have what I need to support that interpretation?”
That difference becomes more important as the case becomes more complicated.
The Pathology Report Becomes Part of a Larger Conversation
Breast pathology does not exist on an island.
Breast care can involve radiologists, surgeons, medical oncologists, radiation oncologists, nurses, genetic counselors, and other professionals. Each person approaches the patient’s situation from a different area of expertise.
The pathologist’s perspective comes from examining the tissue.
I have always valued that multidisciplinary aspect of breast care because no one specialty sees every part of the picture. A pathologist may understand what the tissue shows, while another physician has information from imaging, the procedure, the patient’s history, or other parts of the clinical evaluation.
The goal is not for one specialist to know everything. The goal is for each specialist to contribute what he or she knows particularly well.
That is why I have described one of the most important parts of my career as “serving my community by using my expertise and talents that I have developed over many years of training and clinical practice.”
The expertise is useful because it contributes to something larger than the pathology department.
Why Breast Pathologists Have to Keep Learning
I completed advanced training in surgical pathology and then breast pathology at Mount Sinai, but I never viewed the completion of fellowship as the end of my education.
In fact, one of the realities of practicing medicine for years is realizing how dangerous it would be to think that training alone is enough.
I still read constantly.
I follow breast pathology literature, read journals and new editions of textbooks, and attend continuing medical education programs. My scholarly work has also included research and presentations involving breast disease and diagnostic problems.
Why continue doing that after years in the field?
Because the difficult case does not announce itself in advance.
You cannot decide to learn about an unusual finding only after you encounter it and expect that to substitute for years of preparation. Much of expertise is built quietly, through reading and reviewing cases that may have nothing to do with the specimen sitting in front of you that particular day.
Then, one day, something you learned years earlier may suddenly become relevant.
What I Would Want a Patient to Know While Waiting
Waiting for biopsy results can be difficult, and I would never pretend that understanding pathology makes that uncertainty disappear.
What I would want patients to know is that once the specimen leaves the exam room, the medical work has not stopped. It has moved into a different setting.
Behind the pathology report are people examining the tissue, asking questions, comparing what they see with what they know, and deciding whether the evidence supports the interpretation they are considering.
For me, that responsibility has always brought the work back to its purpose.
I have said that professional success means “good positive patient outcomes directly related to my service.” That remains the standard I find most meaningful.
A pathology report may look like another document in a medical record. To the pathologist who worked on the case, however, it represents something much more human: a patient waiting for an answer, and a responsibility to make the work behind that answer count.